Cart
sales@molnova.com
D-ERYTHRO-SPHINGOSINE
CAS No. 123-78-4
D-ERYTHRO-SPHINGOSINE( Erythrosphingosine | erythro-C18-Sphingosine | trans-4-Sphingenine )
Catalog No. M20525 CAS No. 123-78-4
D-erythro-Sphingosine is a protein kinase C (PKC) inhibitor. D-erythro-Sphingosine (Erythrosphingosine) is also a PP2A activator.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 41 | In Stock |
|
| 10MG | 37 | In Stock |
|
| 25MG | 61 | In Stock |
|
| 50MG | 105 | In Stock |
|
| 100MG | 160 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | 398 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameD-ERYTHRO-SPHINGOSINE
-
NoteResearch use only, not for human use.
-
Brief DescriptionD-erythro-Sphingosine is a protein kinase C (PKC) inhibitor. D-erythro-Sphingosine (Erythrosphingosine) is also a PP2A activator.
-
DescriptionD-erythro-Sphingosine is a protein kinase C (PKC) inhibitor. D-erythro-Sphingosine (Erythrosphingosine) is also a PP2A activator
-
In Vitro——
-
In Vivo——
-
SynonymsErythrosphingosine | erythro-C18-Sphingosine | trans-4-Sphingenine
-
PathwayAngiogenesis
-
TargetPKC
-
RecptorPKC|PP2A|Human Endogenous Metabolite
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number123-78-4
-
Formula Weight299.49
-
Molecular FormulaC18H37NO2
-
Purity>98% (HPLC)
-
SolubilityDMSO:250 mg/mL (834.75 mM)
-
SMILESCCCCCCCCCCCCC\C=C\C(O)C(N)CO
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Khan W A Dobrowsky R El T S et al. Protein kinase C and platelet inhibition by D-erythro-sphingosine: comparison with NN-dimethylsphingosine and commercial preparation.[J]. Biochemical & Biophysical Research Communications 1990 172(2):683-691.
molnova catalog
related products
-
Bisindolylmaleimide ...
Bisindolylmaleimide III is a potent and selective inhibitor of protein kinase C (PKC), specifically interacting with PKCα or ribosomal S6 protein kinase 1 upon activation of these kinases.
-
Miltefosine
Miltefosine is used for the treatment of visceral and cutaneous leishmaniasis, and is undergoing clinical trials for this use in several other countries.
-
BJE6-106
BJE6-106 (B106)?is a potent, selective PKCδ inhibitor with IC50 of 50 nM, displays excellent selectivity over classical PKC isozymes.
